Assembly Biosciences, Inc. (ASMB) — Stock Score Summary

Assembly Biosciences, Inc. (ASMB) has a MoatMap StockRank of 20/100 based on Quality (42/100), Value (38/100), and Momentum (26/100) factor scores. The current signal is STRONG SELL. Assembly Biosciences is a clinical-stage biotech company. It is pre-revenue, highly speculative, and does not possess the validated manufacturing scale or pricing power of a high-quality CDMO.

Assembly Biosciences, Inc. is a clinical-stage biotechnology company focused on developing new oral therapeutics for serious viral diseases, with a primary focus on chronic Hepatitis B virus (HBV) infection. The company leverages its proprietary core inhibitor pipeline to address a significant global health challenge. It operates as a specialized biotech firm dedicated to innovative antiviral drug discovery.

Key Financial Metrics

Price$22.72
Market Cap$550M
P/E (TTM)301.38
P/E (Forward)-8.90
Price/Book1.93
Return on Equity-5.7%
Return on Invested Capital-5.8%
Debt/Equity1.25
Gross Margin8.8%
Operating Margin-138.4%
Revenue Growth-12.8%
Free Cash Flow$-17M

Assembly Biosciences, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Assembly Biosciences, Inc.’s (ASMB) StockRank?
MoatMap’s StockRank for Assembly Biosciences, Inc. (ASMB) is 20/100, with a Strong Sell signal. It is a composite of Quality (42), Value (38), and Momentum (26) factor ranks across MoatMap’s 19,000+ stock universe.
Does Assembly Biosciences, Inc. have an economic moat?
Assembly Biosciences, Inc. (ASMB) has a Quality factor score of 42/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Assembly Biosciences, Inc. a buy, hold, or sell?
MoatMap’s current signal for Assembly Biosciences, Inc. (ASMB) is Strong Sell, based on a StockRank of 20/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Assembly Biosciences, Inc. in?
Assembly Biosciences, Inc. (ASMB) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksASMB deep dive reportAI ChampionsHow we score stocksSense-check another stock